Page last updated: 2024-11-11

7,8-dimethylalloxazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7,8-dimethylalloxazine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

7,8-dimethylisoalloxazine : A 7,8-dimethylbenzo[g]pteridine-2,4-dione that is isoalloxazine substituted by methyl groups at positions 7 and 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

lumichrome : A compound showing blue fluorescence, formed by a photolysis of riboflavin in acid or neutral solution. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5326566
CHEMBL ID1234101
CHEBI ID17781
CHEBI ID37323
SCHEMBL ID194906
MeSH IDM0041789

Synonyms (57)

Synonym
CHEMBL1234101
CHEBI:17781 ,
7,8-dimethylbenzo[g]pteridine-2,4(1h,3h)-dione
CHEBI:37323
7,8-dimethylbenzo[g]pteridine-2,4(3h,10h)-dione
7,8-dimethylisoalloxazine
dimethylisoalloxazine
benzo[g]pteridine-2,4(1h,3h)-dione, 7,8-dimethyl-
LUM ,
OPREA1_454036
alloxazine,8-dimethyl-
1086-80-2
riboflavin lumichrome
nsc-96911
nsc96911
7,8-dimethylalloxazine
lumichrome
benzo[g]pteridine-2,3h)-dione, 7,8-dimethyl-
C01727
2CC7
DB04345
D1066
3CC7321C-61C5-4305-A0F0-EE1334A0C8A1
7,8-dimethyl-1h-benzo[g]pteridine-2,4-dione
AKOS003245099
AKOS003232003
CCG-36441
einecs 214-120-8
benzo(g)pteridine-2,4(1h,3h)-dione, 7,8-dimethyl-
7,8-dimethylbenzo(g)pteridine-2,4(1h,3h)-dione
99u1udj2hm ,
nsc 96911
alloxazine, 7,8-dimethyl-
unii-99u1udj2hm
FT-0603542
7,8-dimethylbenzo(g)pteridine-2,4-(1h,3h)-dione
riboflavin impurity b [ep impurity]
lumichrome [mi]
SCHEMBL194906
7,8-dimethylbenzo[g]pteridine-2,4-diol #
ZJTJUVIJVLLGSP-UHFFFAOYSA-N
lumichrome (i)
HMS3604B12
mfcd00005021
DTXSID70148600
7,8-dimethyl-1h-benzo[g]pteridine-2,4-quinone
J-002180
sr-01000198213
SR-01000198213-1
Q27095157
D78457
AS-56222
7,8-dimethylbenzo[g]pteridine-2,4(1h,3h)-dione; 7,8-dimethylalloxazine; riboflavin lumichrome; 7,8-dimethylisoalloxazine; nsc 96911; riboflavin impurity b
7,8-dimethylbenzo[g]pteridine-2,4(1h,3h)-dione (lumichrome)
HY-115385
CS-0081855
SY051636
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
7,8-dimethylbenzo[g]pteridine-2,4-dione
7,8-dimethylbenzo[g]pteridine-2,4-dione
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (80)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (13.75)18.7374
1990's8 (10.00)18.2507
2000's19 (23.75)29.6817
2010's34 (42.50)24.3611
2020's8 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.39 (24.57)
Research Supply Index4.42 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other81 (98.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]